Effects of N-acetylcysteine against systemic and renal hemodynamic effects of endotoxin in healthy humans

Critical Care Medicine

Volumn 35, Issue 8, 2007, Pages 1869-1875

  Schaller, Georg ^a   Pleiner, Johannes ^a   Mittermayer, Friedrich ^a   Posch, Martin ^a   Kapiotis, Stylianos ^a   Wolzt, Michael ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Antioxidant; Cytokines; Endotoxin; N acetylcysteine; Renal plasma flow; Systemic hemodynamics

Indexed keywords

4 AMINOHIPPURIC ACID; ACETYLCYSTEINE; ANTIHISTAMINIC AGENT; ANTIOXIDANT; CORTICOSTEROID; CYTOKINE; ESCHERICHIA COLI ENDOTOXIN; LIPOPOLYSACCHARIDE; NORADRENALIN; PLACEBO; TUMOR NECROSIS FACTOR ALPHA;

ACUTE KIDNEY FAILURE; ADULT; ARTICLE; BLOOD PRESSURE; BODY TEMPERATURE; CLINICAL TRIAL; CONTINUOUS INFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG ERUPTION; ENDOTOXEMIA; ESCHERICHIA COLI; HUMAN; INFLAMMATION; KIDNEY BLOOD FLOW; KIDNEY FUNCTION; KIDNEY PLASMA FLOW; MALE; PRESSOR RESPONSE; PRIORITY JOURNAL; PULSE RATE; TREATMENT OUTCOME;

ACETYLCYSTEINE; ADULT; BLOOD CIRCULATION; CROSS-OVER STUDIES; CYTOKINES; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FREE RADICAL SCAVENGERS; HUMANS; INFUSIONS, INTRAVENOUS; INTERLEUKIN-1BETA; LIPOPOLYSACCHARIDES; MALE; OXIDATIVE STRESS; RENAL CIRCULATION; SEPSIS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 34547684284     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.CCM.0000275385.45557.25     Document Type: Article

References (53)

1. Haglund U, Gerdin B: Oxygen-free radicals (OFR) and circulatory shock. Circ Shock 1991; 34:405-411
2. Goode HF, Webster NR: Free radicals and antioxidants in sepsis. Crit Care Med 1993; 21:1770-1776
3. Aruoma OI, Halliwell B, Hoey BM, et al: The antioxidant action of N-acetylcysteine: Its reaction with hydrogen peroxide, hydroxyl radical, superoxide, and hypochlorous acid. Free Radic Biol Med 1989; 6:593-597
4. Lucht WD, English DK, Bernard GR, et al: Prevention of release of granulocyte aggregants into sheep lung lymph following endotoxemia by N-acetylcysteine. Am J Med Sci 1987; 294:161-167
5. Zhang H, Spapen H, Nguyen DN, et al: Protective effects of N-acetyl-L-cysteine in endotoxemia. Am J Physiol 1994; 266:H1746-H1754
6. Lopez BL, Snyder JW, Birenbaum DS, et al: N-acetylcysteine enhances endothelium-dependent vasorelaxation in the isolated rat mesenteric artery. Ann Emerg Med 1998; 32:405-410
7. Wright CE, Rees DD, Moncada S: Protective and pathological roles of nitric oxide in endotoxin shock. Cardiovasc Res 1992; 26:48-57
8. Buckley NA, Whyte IM, O'Connell DL, et al: Oral or intravenous N-acetylcysteine: Which is the treatment of choice for acetaminophen (paracetamol) poisoning? J Toxicol Clin Toxicol 1999; 37:759-767
9. Ritter C, Andrades ME, Reinke A, et al: Treatment with N-acetylcysteine plus deferoxamine protects rats against oxidative stress and improves survival in sepsis. Crit Care Med 2004; 32:342-349
10. Ritter C, Andrades ME, Reinke A, et al: Treatment with N-acetylcysteine plus deferoxamine protects rats against oxidative stress and improves survival in sepsis. Crit Care Med. 2004; 32:342-349
11. Spapen H, Zhang H, Demanet C, et al: Does N-acetyl-L-cysteine influence cytokine response during early human septic shock? Chest 1998; 113:1616-1624
12. Galley HF, Howdle PD, Walker BE, et al: The effects of intravenous antioxidants in patients with septic shock. Free Radic Biol Med 1997; 23:768-774
13. Haase M, Haase-Fielitz A, Bagshaw SM, et al: Phase II, randomized, controlled trial of high-dose N-acetylcysteine in high-risk cardiac surgery patients. Crit Care Med 2007; 35:1324-1331
14. Ritter C, da Cunha AA, Echer IC, et al: Effects of N-acetylcysteine plus deferoxamine in lipopolysaccharide-induced acute lung injury in the rat. Crit Care Med 2006; 34:471-477
15. Hsu BG, Yang FL, Lee RP, et al: N-acetylcysteine ameliorates lipopolysaccharide-induced organ damage in conscious rats. J Biomed Sci 2004; 11:152-162
16. Sprong RC, Winkelhuyzen-Janssen AM, Aarsman CJ, et al: Low-dose N-acetylcysteine protects rats against endotoxin-mediated oxidative stress, but high-dose increases mortality. Am J Respir Crit Care Med 1998; 157:1283-1293
17. Molnar Z, Shearer E, Lowe D: N-acetylcysteine treatment to prevent the progression of multisystem organ failure: A prospective, randomized, placebo-controlled study. Crit Care Med 1999; 27:1100-1104
18. Ortolani O, Conti A, De Gaudio AR, et al: The effect of glutathione and N-acetylcysteine on lipoperoxidative damage in patients with early septic shock. Am J Respir Crit Care Med 2000; 161:1907-1911
19. Rank N, Michel C, Haertel C, et al: N-acetylcysteine increases liver blood flow and improves liver function in septic shock patients: Results of a prospective, randomized, double-blind study. Crit Care Med 2000; 28:3799-3807
20. Peake SL, Moran JL, Leppard PI: N-acetyl-L-cysteine depresses cardiac performance in patients with septic shock. Crit Care Med 1996; 24:1302-1310
21. Pleiner J, Heere-Ress E, Langenberger H, et al: Adrenoceptor hyporeactivity is responsible for Escherichia coli endotoxin-induced acute vascular dysfunction in humans. Arterioscler Thromb Vasc Biol 2002; 22:95-100
22. Cuzzocrea S, Mazzon E, Di Paola R, et al: A role for nitric oxide-mediated peroxynitrite formation in a model of endotoxin induced shock. J Pharmacol Exp Ther 2006; 319:73-81
23. Pleiner J, Mittermayer F, Schaller G, et al: Inflammation-induced vasoconstrictor hyporeactivity is caused by oxidative stress. J Am Coll Cardiol 2003; 42:1656-1662
24. Jackson TS, Xu A, Vita JA, et al: Ascorbate prevents the interaction of superoxide and nitric oxide only at very high physiological concentrations. Circ Res 1998; 83:916-922
25. Graumlich JF, Ludden TM, Conry-Cantilena C, et al: Pharmacokinetic model of ascorbic acid in healthy male volunteers during depletion and repletion. Pharm Res 1997; 14:1133-1139
26. Schnackenberg CG: Oxygen radicals in cardiovascular-renal disease. Curr Opin Pharmacol 2002; 2:121-125
27. Langenberg C, Bellomo R, May C, et al: Renal blood flow in sepsis. Crit Care 2005; 9:R363-R374
28. Zurovsky Y, Gispaan I: Antioxidants attenuate endotoxin-induced acute renal failure in rats. Am J Kidney Dis 1995; 25:51-57
29. Conesa EL, Valero F, Nadal JC, et al: N-acetyl-L-cysteine improves renal medullary hypoperfusion in acute renal failure. Am J Physiol Regul Integr Comp Physiol 2001; 281:R730-R737
30. DiMari J, Megyesi J, Udvarhelyi N, et al: N-acetyl cysteine ameliorates ischemic renal failure. Am J Physiol 1997; 272:F292-F298
31. Granowitz EV, Santos AA, Poutsiaka DD, et al: Production of interleukin-1-receptor antagonist during experimental endotoxaemia. Lancet 1991; 338:1423-1424
32. Nakamura H: Thioredoxin and its related molecules: Update 2005. Antioxid Redox Signal 2006; 7:823-828
33. Callister ME, Burke-Gaffney A, Quinlan GJ, et al: Extracellular thioredoxin levels are increased in patients with acute lung injury. Thorax 2006; 61:521-527
34. Schnurr E, Lahme W, Kuppers H: Measurement of renal clearance of inulin and PAH in the steady state without urine collection. Clin Nephrol 1980; 13:26-29
35. Sambo P, Amico D, Giacomelli R, et al: Intravenous N-acetylcysteine for treatment of Raynaud's phenomenon secondary to systemic sclerosis: A pilot study. J Rheumatol 2001; 28:2257-2262
36. Wolzt M, Schmetterer L, Rheinberger A, et al: Comparison of non-invasive methods for the assessment of haemodynamic drug effects in healthy male and female volunteers: Sex differences in cardiovascular responsiveness. Br J Clin Pharmacol 1995; 39:347-359
37. R Development Core Team: R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing, Vienna, Austria. ISBN 3-900051-07-0, 2006. Available at: http://www.R-project.org. Accessed on August 1, 2006
38. Spapen HD, Diltoer MW, Nguyen DN, et al: Effects of N-acetylcysteine on microalbuminuria and organ failure in acute severe sepsis: Results of a pilot study. Chest. 2005; 127:1413-1419
39. Tanudji M, Hevi S, Chuck SL: The nonclassic secretion of thioredoxin is not sensitive to redox state. Am J Physiol Cell Physiol 2003; 284:C1272-C1279
40. Cohen JJ, Black AJ, Wertheim SJ: Direct effects of endotoxin on the function of the isolated perfused rat kidney. Kidney Int 1990; 37:1219-1226
41. Gullichsen E: Renal perfusion and metabolism in experimental endotoxin shock. Acta Chir Scand Suppl 1991; 560:7-31
42. Cohen RI, Hassell AM, Marzouk K, et al: Renal effects of nitric oxide in endotoxemia. Am J Respir Crit Care Med 2001; 164:1890-1895
43. Wang W, Mitra A, Poole B, et al: Endothelial nitric oxide synthase-deficient mice exhibit increased susceptibility to endotoxin-induced acute renal failure. Am J Physiol Renal Physiol 2004; 287:F1044-F1048
44. Wang P, Zhou M, Rana MW, et al: Differential alterations in microvascular perfusion in various organs during early and late sepsis. Am J Physiol 1992; 263:G38-G43
45. Wolzt M, Schmetterer L, Ferber W, et al: Effect of nitric oxide synthase inhibition on renal hemodynamics in humans: Reversal by L-arginine. Am J Physiol 1997; 272:F178-F182
46. Langenberg C, Wan L, Egi M, et al: Renal blood flow in experimental septic acute renal failure. Kidney Int 2006; 69:1996-2002
47. Hoffmann U, Fischereder M, Kruger B, et al: The value of N-acetylcysteine in the prevention of radiocontrast agent-induced nephropathy seems questionable. J Am Soc Nephrol 2004; 15:407-410
48. Peristeris P, Clark BD, Gatti S, et al: N-acetylcysteine and glutathione as inhibitors of tumor necrosis factor production. Cell Immunol 1992; 140:390-399
49. Bakker J, Zhang H, Depierreux M, et al: Effects of N-acetylcysteine in endotoxic shock. J Crit Care 1994; 9:236-243
50. Vassilakopoulos T, Karatza MH, Katsaounou P, et al: Antioxidants attenuate the plasma cytokine response to exercise in humans. J Appl Physiol 2003; 94:1025-1032
51. Chan TY, Critchley JA: Adverse reactions to intravenous N-acetylcysteine in Chinese patients with paracetamol (acetaminophen) poisoning. Hum Exp Toxicol 1994; 13:542-544
52. Bailey B, McGuigan MA: Management of anaphylactoid reactions to intravenous N-acetylcysteine. Ann Emerg Med 1998; 31:710-715
53. Appelboam AV, Dargan PI, Knighton J: Fatal anaphylactoid reaction to N-acetylcysteine: Caution in patients with asthma. Emerg Med J 2002; 19:594-595